Weston P. (“Wes”) Harty is a member of Garfunkel Wild’s Mergers and Acquisitions, Emerging Companies, IP and Trademark, and Technology and Cybersecurity practice groups. Wes also has a role in the development of Garfunkel Wild’s associate training program curriculum.
Wes’ varied practice focuses on negotiating and facilitating corporate transactions including venture financing, mergers, acquisitions, and enterprise sale transactions; and forming and growing multi-state management and professional practice entities. Wes also concentrates his practice counseling on commercial and corporate governance matters for his for-profit and not-for-profit clients. In this space, he advises on HIT transactions; intellectual property development, licensing, and collaboration arrangements; research and clinical trial agreements; and related regulatory and compliance matters.
Wes joined Garfunkel Wild in 2019 from the Mergers and Acquisitions practice group of a North Carolina firm where he focused on general corporate transactional and commercial matters.
Experience
Assisted a group physician practice in unwinding a joint venture with a hospital system and its subsequent affiliation with a nationwide provider group.
Represented an emerging life sciences start-up secure venture capital financing.
Facilitated the affiliation of several professional practices with hospital and private equity-backed provider groups.
Negotiated development, license, and collaboration agreements involving a life science company’s patented human therapeutic.
Negotiated development, license, and collaboration agreements involving a life science company’s patented human therapeutic.
Associate, Weston Harty authored the article "Franchise Regulations in the Context of the MSO Model", published in the New York State Bar Association Health Law Journal (2023 - Vol. 28 - No.1).
Additional speaking & writing
Publications
Co-authored chapter entitled "Regulated Medical Waste" in the Legal Manual for New York Physicians (Sixth Edition)